Crossmark

Granulomatous/sarcoid-like lesions associated with checkpoint inhibitors: a marker of therapy response in a subset of melanoma patients

Crossref DOI link: https://doi.org/10.1186/s40425-018-0323-0

Published Online: 2018-02-12

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Tetzlaff, Michael T.

Nelson, Kelly C.

Diab, Adi

Staerkel, Gregg A.

Nagarajan, Priyadharsini

Torres-Cabala, Carlos A.

Chasen, Beth A.

Wargo, Jennifer A.

Prieto, Victor G.

Amaria, Rodabe N.

Curry, Jonathan L.
More Information

Article History

Received: 28 October 2017

Accepted: 26 January 2018

First Online: 12 February 2018

Ethics approval and consent to participate

: The study was approved by the Institutional Review Board at The University of Texas MD Anderson Cancer Center.

: Not applicable

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.